Abiopharma

Innovative Eyewear, Inc. Announces Record-Breaking 65% Annual Sales Growth in 2025 & Insider Buying Intent

AbbVie to Host Full-Year and Fourth-Quarter 2025 Earnings Conference Call

Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Verrica Pharmaceuticals Announces First Patient Dosed in Phase 3 Program Evaluating YCANTH® (VP-102) for the Treatment of Common Warts

SOPHiA GENETICS and MD Anderson Announce Strategic Collaboration to Accelerate AI-Driven Precision Oncology

Alterity Therapeutics Limited (ATHE) Files Form 6-K

Emergent BioSolutions to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

BrainsWay Announces First Coverage Policy for Accelerated Deep TMS™

BRAINSWAY (BWAY) Files Form 6-K

Arrowhead Pharmaceuticals Announces NMPA Approval of REDEMPLO® (plozasiran) for Familial Chylomicronemia Syndrome (FCS) in China

Sotera Health to Present at the 44th Annual J.P. Morgan Healthcare Conference

TG Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Dyne Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference

Vera Therapeutics Announces U.S. FDA Granted Priority Review to Biologics License Application for Atacicept for Treatment of Adults with IgA Nephropathy

Intellia Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference